Period of time： 2014年4期
Publisher： Informa Healthcare
Founded in： 1991
Total resources： 179
ISSN： 1354-3776
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Therapeutic Patents,volume 15,issue 4
Menu
Recent advances towards the discovery of ORL-1 receptor agonists and antagonists
By Bignan Gilles C,Connolly Peter J,Middleton Steven A in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.
Access to resources
Recommend
NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.New insights into the biological therapy of Crohn’s disease
By Hassan Cesare,Zullo Angelo,Campo Salvatore MA,Morini Sergio in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.MMP/ADAM inhibitors: therapeutic potential for psoriasis
By Yokota Koichi,Nishimura Shin-Ichiro in (2005)
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.Non-steroidal glucocorticoid agonists
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.Cystic fibrosis transmembrane regulator (CFTR) modulators
Expert Opinion on Therapeutic Patents,volume 15,issue 4 , Vol. 15, Iss. 4, 2005-04 , pp.